Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6631 AL 6645

Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider

Biondi E.

Neurol Sci. 2011 Apr;32(2):195-201. doi: 10.1007/s10072-010-0440-0. Epub 2010 Oct 19.

Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany

Guo S, Hernandez L, Wasiak R, Gaudig M.

J Med Econ. 2010;13(4):641-54. doi: 10.3111/13696998.2010.528101. Epub 2010 Oct 19.

[Alteration of calcium signaling as one of the mechanisms of Alzheimer's disease and diabetic polyneuropathy]

Kostiuk OP, Korol' TIu, Korol' SV, Romanenko SV, Pinchenko VO, Kostiuk PH.

Fiziol Zh (1994). 2010;56(4):130-8.

Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains

Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Zhu HQ, Zhang QQ, Zhang YD, Xu J.

Brain Res. 2011 Jan 12;1368:239-47. doi: 10.1016/j.brainres.2010.10.053. Epub 2010 Oct 21.

Is dementia preventable? Focus on Alzheimer's disease

Barak Y, Aizenberg D.

Expert Rev Neurother. 2010 Nov;10(11):1689-98. doi: 10.1586/ern.10.159.

[Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)]

Agüera-Ortiz LF; Grupo de Investigadores del Estudio MEMORY.

Rev Neurol. 2010 Nov 1;51(9):525-34.

Switching cholinesterase inhibitors in older adults with dementia

Massoud F, Desmarais JE, Gauthier S.

Int Psychogeriatr. 2011 Apr;23(3):372-8. doi: 10.1017/S1041610210001985. Epub 2010 Nov 3.

Clinical and economic characteristics associated with direct costs of Alzheimer's, frontotemporal and vascular dementia in Argentina

Rojas G, Bartoloni L, Dillon C, Serrano CM, Iturry M, Allegri RF.

Int Psychogeriatr. 2011 May;23(4):554-61. doi: 10.1017/S1041610210002012. Epub 2010 Nov 3.

In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease

Bitner RS, Markosyan S, Nikkel AL, Brioni JD.

Neuropharmacology. 2011 Feb-Mar;60(2-3):460-6. doi: 10.1016/j.neuropharm.2010.10.026. Epub 2010 Oct 31.

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.

JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510.

Inflammation and Alzheimer's disease

Lee YJ, Han SB, Nam SY, Oh KW, Hong JT.

Arch Pharm Res. 2010 Oct;33(10):1539-56. doi: 10.1007/s12272-010-1006-7. Epub 2010 Oct 30.

Potential therapeutic agents against Alzheimer's disease from natural sources

Park SY.

Arch Pharm Res. 2010 Oct;33(10):1589-609. doi: 10.1007/s12272-010-1010-y. Epub 2010 Oct 30.

Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine

McCampbell A, Wessner K, Marlatt MW, Wolffe C, Toolan D, Podtelezhnikov A, Yeh S, Zhang R, Szczerba P, Tanis KQ, Majercak J, Ray WJ, Savage M.

J Neurochem. 2011 Jan;116(1):82-92. doi: 10.1111/j.1471-4159.2010.07087.x. Epub 2010 Dec 2.

A meta-analysis of mood stabilizers for Alzheimer's disease

Xiao H, Su Y, Cao X, Sun S, Liang Z.

J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):652-8. doi: 10.1007/s11596-010-0559-5. Epub 2010 Nov 10.

Natural products as a source of Alzheimer's drug leads

Williams P, Sorribas A, Howes MJ.

Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias